Type 2 Diabetes Study – Seeking Volunteers Who Treat with Any Combination of Medications, Except Insulin.
-
- STATUS
- Recruiting
Summary
We are currently seeking volunteers who are diagnosed with Type 2 Diabetes and who are treating with any combination of medications including any of the following:
- Metformin
- Sulfonylureas (Glyburide, Glipizide, or Glimepiride.)
- Glinides (Prandin or Starlix.)
- DPP-4 inhibitors (Januvia, Onglyza, Tradjenta, or Nesina.)
- SLGT-2 inhibitors (Farxiga, Invokana, or Jardiance.)
- TZDs (Avandia, Actos, or Rezulin.)
- Alpha-glucosidase inhibitors (Precose, Glyset, or Voglibose.)
- Oral or injectable GLP-1 RAs (Byetta, Bydureon, Victoza, Trulicity, Tanzeum, Ozempic, or Rybelsus-[oral].)
This is a study of an investigational once weekly basal insulin, that may help improve blood sugar level control.
Participants will be assigned to one of two groups: half of all participants will take the investigational insulin once a week, the other half will take Lantus insulin once daily. If currently taking them, participants will stop taking any Sulfonylureas (Glyburide, Glipizide, Glimepiride) and Glinides (Prandin or Starlix).
Participants will continue taking their other diabetes medications. Participants must be willing to check their blood sugars at least once a day. Also, they must be willing to wear a blinded Dexcom G6 continuous glucose monitor on their arms on 4 separate occasions during the study.
For more information, please click here: https://rainier-research.com/studies/type-2-diabetes-study-seeking-volunteers-who-treat-with-any-combination-of-medications-except-insulin/
Description
Study Length: 80 weeks, with 37 clinic visits, and 26 telephone visits.
Target Age: 18+ years old.
Benefits: Study medication, study related physical exams, EKG’s, eye exams, lab work, a glucose meter, test strips and other supplies.
Stipend: $2550 for study completion.
Details
| Condition | Diabetes Mellitus, Type 2, Diabetes Mellitus Type 2 |
|---|---|
| Clinical Study Identifier | TX261389 |
| Last Modified on | 25 January 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer